InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (10 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
10
T+90 hit rate
33%
T+90 mean return
-29.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Thomsen Jillian B., Directrice comptable principale. Officer active across 2 companies, notably NEKTAR THERAPEUTICS. Cumulatively, 18 filings have been recorded. Breakdown: 0 buy · 10 sells. Total volume traded: €829k. History available since 17 May 2021. The latest transaction was disclosed on 16 February 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations18 total
10,267 shares@ US$3.004.6% of flowCommon StockSEC:0001209191-23-010953:0
11,095 shares@ US$3.576.1% of flowCommon StockSEC:0001209191-22-057966:0
165,938 shares0Common StockSEC:0001209191-22-046487:0
10,950 shares0Common StockSEC:0001209191-22-029903:0
2,363 shares@ US$10.950.0010% mcap12.7% of flowCommon StockSEC:0001209191-22-011439
2,363 shares@ US$10.950.0010% mcap4.1% of flowCommon StockSEC:0001209191-22-011439:0
21,200 shares0Common StockSEC:0001209191-21-070693
21,200 shares0Common StockSEC:0001209191-21-070693:0
14,900 shares0Common StockSEC:0001209191-21-065223:0
14,900 shares0Common StockSEC:0001209191-21-065223
13,339 shares@ US$13.830.0066% mcap27.9% of flowCommon StockSEC:0001209191-21-052390:0
13,339 shares@ US$13.8325.0% of flowCommon StockSEC:0001209191-21-052390
13,391 shares@ US$18.30100.0% of flowCommon StockSEC:0001209191-21-034188
13,391 shares@ US$18.300.0084% mcap36.0% of flowCommon StockSEC:0001209191-21-034188:0
15,000 sharesCommon StockSEC:0001209191-16-098170:0
15,000 sharesCommon StockSEC:0001209191-16-098170:1
15,000 sharesCommon StockSEC:0001209191-16-092947:0
15,000 sharesCommon StockSEC:0001209191-16-092947:1
18 of 18 declarations
About Thomsen Jillian B.
Jillian B. Thomsen is the Senior Vice President and Chief Accounting Officer at NEKTAR THERAPEUTICS. She oversees the company's accounting operations, ensuring compliance and efficiency of processes. Thomsen plays a key role in managing financial resources and in strategic decision-making.
